461 results about "Counterion" patented technology

This invention relates to antireflective coatings comprising polymeric polyoxyalkylenated colorants. More particularly, the present invention relates to antireflective coatings for utilization in forming thin layers between reflective substrates and photoresist coatings. Such antireflective coatings are very useful and beneficial within the production and fabrication of semiconductors through photolithographic procedures due to the liquid, non-crystallizing nature of polyoxyalkylenated colorants, and the lack of potentially damaging counterions, metals, and/or electrolytes within the inventive antireflective colored coatings. The inventive coatings may also be applied on lenses, mirrors, and other optical components. Methods of forming such antireflective coatings are also contemplated within this invention.

A method for making hollow nanoparticles, comprises a) providing an amount of a polyelectrolyte having a charge, b) providing an amount of a counterion having a valence of at least 2, c) combining the polyelectrolyte and the counterion in a solution such that the polyelectrolyte self-assembles to form spherical aggregates, and d) adding nanoparticles to the solution such that nanoparticles arrange themselves around the spherical aggregates. The polyelectrolyte may have a positive or negative charge. The charge ratio R of total charge of the counterions to the total charge of the polyelectrolyte is greater than 1.0.

A formulation for coating a transdermal delivery device having a plurality of stratum corneum-piercing microprojections, the formulation including a biologically active agent and at least one viscosity-enhancing counterion. Preferably, the formulation has a viscosity in the range of about 20-200 cp.

The present invention relates to new addition salts of lercanidipine comprising lercanidipine and an acid counterion wherein the acid counterion is selected from the group consisting of: (i) inorganic acids, (ii) sulfonic acids, (iii) monocarboxylic acids, (iv) dicarboxylic acids, (v) tricarboxylic acids, and (vi) aromatic sulfonimides, with the proviso that said acid counterion is not hydrochloric acid.

A method for removing a target DNA fragment having a predetermined base-pair length from a mixture of DNA fragments comprises the following steps. A mixture of DNA fragments which may contain the target DNA fragments is applied to a separation column containing media having a nonpolar, nonporous surface, the mixture of DNA fragments being in a first solvent mixture containing a counterion and a DNA binding concentration of driving solvent in a cosolvent. The target DNA fragments are separated from the media by contacting it with a second solvent solution containing a counterion and a concentration of driving solvent in cosolvent which has been predetermined to remove DNA fragments having the target DNA fragment base pair length from the media. The target DNA fragments can be collected and optionally amplified. When the method is being applied to collect a putative fragment, if present, no DNA fragments having the base pair length of the target DNA could be present in the mixture. Alternatively, DNA fragments having the base pair length of the target DNA are present in the mixture. The disclosure also describes an ambient or low pressure device for separating polynucleotide fragments from a mixture of polynucleotide fragments comprises a tube having an upper solution input chamber, a lower eluant receiving chamber, and a fixed unit of separation media supported therein. The separation media has nonpolar separation surfaces which are free from multivalent cations which would react with counterion to form an insoluble polar coating on the surface of the separation media.

The present invention discloses printing plates comprising a substrate and a radiation-absorptive layer, wherein the radiation-absorptive layer comprises at least one modified pigment product. The modified pigment product comprises a pigment having attached at least one organic group and at least one amphiphilic counterion. Methods of imaging printing plates are also disclosed.

The present invention relates to liquid sustained release suspension dosage forms comprising ionized forms of water-soluble drugs. In particular, the invention encompasses a liquid form controlled release drug composition comprising a dispersed phase comprising an ion-exchange matrix drug complex comprising a pharmaceutically acceptable ion-exchange matrix and a water-soluble electrolytic drug associated with the ion-exchange matrix, wherein the surface charge of the ion-exchange matrix is opposite that of the electrolytic drug and a dispersion medium substantially free of diffusible counterions, further comprising a polyelectrolyte having the same charge as the electrolytic drug. The invention also provides methods for preparing such compositions and methods of treatment.

A method for making inhomogeneous microparticles comprises a) providing an amount of each of at least two polyelectrolytes having a charge, b) providing an amount of a counterion having a valence of at least 2, c) combining the polyelectrolytes and the counterion in a solution such that the polyelectrolyte self-assembles to form inhomogeneous aggregates, and d) adding nanoparticles to the solution such that nanoparticles arrange themselves around the inhomogeneous aggregates to form inhomogeneous particles. The polyelectrolyte may have a positive or negative charge. The charge ratio R of total charge of the counterions to the total charge of the polyelectrolyte may be greater than 1.0.

Various embodiments disclosed relate to a composition including a crosslinkable ampholyte polymer or a crosslinked product of the same, methods of making and using the composition, and systems including the composition. In various embodiments, the present invention provides a method of treating a subterranean formation. The method can include obtaining or providing a composition including a crosslinkable ampholyte polymer. The crosslinkable ampholyte polymer can include an ethylene repeating unit including a —C(O)NH₂ group, an ethylene repeating unit including a —S(O)₂OR¹ group, and an ethylene repeating unit comprising an —N⁺R²₃X⁻ group. At each occurrence, R¹ can be independently selected from the group consisting of —H and a counterion. At each occurrence, R² can be independently substituted or unsubstituted (C₁-C₂₀)hydrocarbyl. At each occurrence, X⁻ can be independently a counterion. The composition can also include at least one crosslinker. The method can include placing the composition in a subterranean formation.

An electric double-layer capacitor comprising an electrode containing an activated carbon, an electrolytic solution containing an electrolyte and a separator, wherein the electrolyte is an imidazolium salt represented by the following formula (1)

(wherein R and R′ each independently represent alkyl group having 1 to 6 carbon atoms, R¹ to R³ each independently represent hydrogen atom or alkyl group having 1 to 6 carbon atoms and X⁻ represents a counter ion), and

the activated carbon is produced by carbonizing an organic aerogel obtained by polymerizing a phenolic compound having at least one hydroxyl group in its molecule with an aldehyde compound in an aqueous solvent in the presence of a basic catalyst.

An endotoxin adsorption system of the present invention comprises a combination of a cation exchange resin having sodium as a counter ion and a cation exchange resin having sodium and one or more metal ions other than sodium as a counter ion, and adsorbs an endotoxin without decreasing of the concentration of cations.

A lithium energy storage device comprising at least one positive electrode, at least one negative electrode, and an ionic liquid electrolyte comprising bis(fluorosulfonyl)imide (FSI) as the anion and a cation counterion, and lithium ions at a level of greater than 0.3 mol/kg of ionic liquid, and not more than 1.5 mol/kg of ionic liquid. Also described is a lithium energy storage device comprising an FSI ionic liquid electrolyte and LiBF4 or LiPF6 as the lithium salt. Also described is a lithium energy storage device comprising an FSI ionic liquid electrolyte and a positive electrode comprising lithium metal phosphate, in which the metal is a first-row transition metal, or a doped derivate thereof.

The invention relates to a method for producing the optically active alkanols of formula (I), wherein n is an integer of from 0 to 5; Cyc represents an optionally substituted, mononuclear or polynuclear, saturated or unsaturated, carbocylic or heterocyclic ring, and R¹ represents halogen, SH, OH, NO₂, NR²R³ or NR²R³R⁴⁺X⁻, wherein R², R³ and R⁴ independently represent H or a lower alkyl or lower alkoxy group and X⁻ represents a counterion. According to the invention, an enzyme (E) selected from the groups of dehydrogenases, aldehyde reductases and carbonyl reductases is incubated in a medium containing the alkanone of formula (II), wherein n, Cyc and R¹ are defined as above, in the presence of reduction equivalents. The compound of formula (II) is enzymatically reduced to the compound of formula (I) and the reduction equivalents consumed during reaction are regenerated by reacting a sacrificial alcohol to the corresponding sacrificial ketone using enzyme (E) and at least partially removing the sacrificial ketone from the reaction medium, and then isolating the product (I) so produced.

A method for the encapsulation and triggered-release of water-soluble or water-dispersible materials. The method comprises a) providing an amount of electrolyte having a charge, b) providing an amount of counterion having a valence of at least 2, c) combining the polyelectrolyte and the counterion in a solution such that the polyelectrolyte self-assembles to form aggregates, d) adding a compound to be encapsulated, and e) adding nanoparticles to the solution such that nanoparticles arrange themselves around the aggregates. Release of the encapsulated species is triggered by disassembly or deformation of the microcapsules though disruption of the charge interactions. This method is specifically useful for the controlled viscosity reduction of the fracturing fluids commonly utilized in the oil field.

The invention provides conjugated polymers that have good solubility and semiconductivity, and that display high photoluminescent and electroluminescent efficiency. Representative polymers containing monomer units having the general structure of formula (I)

wherein: Ar¹ and Ar² are independently selected from the group consisting of monocyclic, bicyclic and polycyclic arylene, heteroarylene, substituted arylene and substituted heteroarylene groups; L is alkylene, alkenylene, substituted alkylene, substituted alkenylene, heteroalkylene, heteroalkenylene, substituted heteroalkylene, substituted heteroalkenylene, arylene, heteroarylene, substituted arylene, substituted heteroarylene, or a combination thereof; Q is a heteroatom; m is zero or 1; p is zero or 1, and q is zero or 1, with the proviso that when p is zero, then q is zero; x is zero or 1; Q¹ and Q² are independently selected from the group consisting of H, aryl, heteroaryl, substituted aryl, substituted heteroaryl, alkyl, substituted alkyl, heteroalkyl, and substituted heteroalkyl, and Q³ is selected from the group consisting of alkyl, substituted alkyl, heteroalkyl, and substituted heteroalkyl, with the proviso that when m is 1, Q¹ and Q² are other than H; and A⁻ is a negatively charged counterion. Electroluminescent and other devices containing a polymer of the invention are also provided.

A process for preparing regioselectively an optically active 1-halogeno-2-hydroxypropyl compound of the following formula;

• • wherein X is halogen atom and Nu is a heteroatom having a substituent,

and an optically active glycidyl compound of the formula;

which comprises reacting an optically active epihalohydrin of the formula;

with a neucleophilic agent,

in the presence of a metal complex of the formula;

wherein n is an integer of 0, 1 or 2, Y¹, Y² and Y³ are hydrogen atom, etc., and Y² and Y³ may form a ring such as benzene, A is a counterion and M is a metal ion, and further subjecting the compound (4) to reaction with a base to prepare the optically active glycidyl compound (5).